Geovax Labs Inc GOVX

$1.71 -0.33 (-16.18%)

Valuation

Market cap
627,000
Revenue TTM
$2,490,000
Net income TTM
$-21,460,000
P/E (trailing)
0.00
P/E (forward)
—
Profit margin
-861.85%
Debt to equity
0.00

Trading

Volume
97,600
Avg volume
38,963
Day's range
$1.57 – $2.20
Shares out
307,000
Stochastic %K
5%
Beta
3.85
Analysts
Moderate Buy
Price target
$227.82

Price

Company profile

GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms in the United States. It develops GEO-CM04S1, a vaccine candidate that is in Phase 2 clinical trial for the treatment of preventive COVID-19; Gedeptin, a novel patented product/technology for the treatment of solid tumors, and Phas...

Show more

GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms in the United States. It develops GEO-CM04S1, a vaccine candidate that is in Phase 2 clinical trial for the treatment of preventive COVID-19; Gedeptin, a novel patented product/technology for the treatment of solid tumors, and Phase 1/2 clinical trial for the treatment of advanced head and neck squamous cell carcinoma; and GEO-CM02, a pan-coronavirus vaccine. In addition, the company offers GEO-MVA-MUC1, a vaccine candidate, which is in preclinical trial for the treatment of solid tumor cancers; GEO-ZM02, a vaccine candidate, which is in preclinical trial for the treatment of Zika; GEO-EMO1-Z, which is in preclinical trial for the treatment of Ebola Zaire; GEO-EMO1-S, which is in preclinical trial for the treatment of Ebola Sudan; GEO-MM01 treatment for marburg; and GEO-MVA for the treatment of Mpox and small pox. It has collaboration and partnership agreements with the National Institute of Allergy and Infectious Diseases of the National Institutes of Health; and the U.S. Department of Defense. GeoVax Labs, Inc. was incorporated in 1988 and is based in Smyrna, Georgia.

Industry
Biotechnology
Sector
Healthcare
Phone
678 384 7220
Website
https://www.geovax.com
Address
1955 Lake Park Drive, Suite 380, Smyrna, United States

Latest news

Stocktwits

TheBanker_ Nov 13, 9:12 PM
CLRO getting bought up now and starting a run! Looks like shorts overextended and now they trapped below! parabolic potential on CLRO about to run guys!! $TNXP $GOVX $IXHL $USAR ~#
0 replies
ReversalRuler Nov 13, 6:48 PM
If you’ve ever wanted to catch a short squeeze early instead of watching it rip after the fact, this group is built for that. Sharing momentum, setups, and what we’re watching as it develops, not when it’s already gone. Click link and join for Free ⭐ $COSM $ARAI $SLXN $GOVX .
0 replies
d_risk Nov 13, 2:42 AM
$GOVX - GeoVax Labs, Inc. - 10Q - Updated Risk Factors Nasdaq staff issued a delisting determination over the bid-price shortfall. A hearing request stayed further action. #riskfactors #secfilings 🟢 Added 🟠 Removed https://d-risk.ai/GOVX?filing=Gya5nN6tWQVQQMb2hokJn
0 replies
MisterRagnirLothbrok Nov 12, 8:53 PM
Made some decent money this month so far. 💯 Check em out below, they called some bangers ahead of the runs Tap in below , best FREE group of bulls i know 🔥 $LKNCY $TNXP $GOVX very cheap here
1 replies
ReversalRuler Nov 12, 8:35 PM
If you’ve ever wanted to catch a short squeeze early instead of watching it rip after the fact, this group is built for that. Sharing momentum, setups, and what we’re watching as it develops, not when it’s already gone. Click link and join for Free ⭐ $SLXN $GOVX $NCI $JOB ..
0 replies
ReversalRuler Nov 12, 6:22 PM
$SLXN $GOVX $OFAL $NCI ...
0 replies
TheRealShortSqueezy Nov 12, 3:40 PM
Just like $GOVX Yesterday, $ARAI had too many red flags. Now its down from open at 2.80$ to 1.86$.
0 replies
DeezNuttz Nov 12, 3:23 PM
$GOVX Another RS!?!
0 replies